Analytical Data
-
基因名
TAPA1
- Application
-
别名
TAPA1；TAPA1；TSPAN28；CD81 antigen
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P60033
-
表达区间
25-127aa
-
氨基酸序列
GGVILGVALWLRHDPQTTNLLYLELGDKPAPNTFYVGIYILIAVGAVMMF VGFLGCYGAIQESQCLLGTFFTCLVILFACEVAAGIWGFVNKDQIAKDVK QFY
-
分子量
37 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TAPA1, or Tumor Associated Protein 1, is a receptor-type protein that has garnered significant attention in the field of cancer research due to its potential association with tumor progression and metastasis. Studies have revealed that TAPA1 is overexpressed in various malignancies, suggesting its role as a biomarker for cancer diagnosis and prognosis. The protein facilitates cellular processes such as migration, adhesion, and invasion, which are critical for cancer cell dissemination. Understanding the mechanisms underlying TAPA1 function can offer insights into tumor biology and potentially unveil therapeutic targets. Recent advancements in recombinant protein technology have enabled the production of TAPA1 in vitro, providing a valuable tool for further functional studies. Researchers are actively investigating the interactions of TAPA1 with other cellular molecules to elucidate its involvement in signaling pathways and the tumor microenvironment. As the scientific community continues to explore the intricate relationship between TAPA1 and cancer, the development of TAPA1-based therapies could represent a promising avenue for improving clinical outcomes in cancer patients.
